INVESTORS CAREERS RESOURCES Corporate Financial 25/10/2021 Oncodesign has appointed Karine Lignel as Group Chief Development Officer Oncodesign adds a new high-level competence to its COMEX to achieve its external growth objectives with Karine Lignel. Read more Financial 16/09/2021 Oncodesign announces its results for the first half of 2021 Read all the financial information of Oncodesign and its Business Units Service, Biotech and Artificial Intelligence. Read more Financial 21/07/2021 Oncodesign announces a sharp increase in turnover in the first half of 2021 Group turnover up by 33% at €15.8M. Despite the global health crisis, which continues to limit international travel... Read more Corporate Financial 05/07/2021 Oncodesign announces the appointment of Aline Aubertin as an independent director of the Board of Directors Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director. Read more Service Financial 28/06/2021 Oncodesign launches its new DRIVE-MRT™ service offer in partnership with Covalab, CheMatech and ABX-CRO [Press Release] Explore our brand new service offer DRIVE-MRT. it allows the rationalization, design and optimization of targeted radiopharmaceutical products that are effective against certain metastatic cancers. Biotech Financial 24/06/2021 Oncodesign provides an update on its progress on RIPK2 [Press Release] Find the update of the RIPK2 program and the start of new programs associated with Nanocyclix. Read more Financial 18/06/2021 Oncodesign maintains its revenue and operating income at €38 million in 2020… [Press Release] Oncodesign maintains its revenue and operating income at €38 million in 2020 and is anticipating an operating profit for the 2nd straight year, within the context of the global public health crisis Read more A.I Financial 18/05/2021 InterSystems & Oncodesign partner for the optimization of data use to enhance and accelerate Drug Discovery processes in oncology Read PRess Release to have an insight on how to organize & leverage healthcare data to accelerate the search for new treatments in oncology using AI. Read more Financial 29/01/2021 [FR] Biotech Info – Oncodesign, la médecine de précision en ligne de mire Financial 28/01/2021 Oncodesign maintains its revenue and operating income at €38 million in 2020 and is anticipating an operating profit for the 2nd straight year Financial 06/10/2020 Oncodesign obtains €15.9 million of non-dilutive financing in the form of a State-Guaranteed Loan within the context of the COVID-19 pandemic Financial 10/09/2020 Oncodesign announces a capital increase reserved for the Company’s Management Committee 1 2 … 9 10 Contact-us 18 rue Jean Mazen - FR - 21000 Dijon Tel.+33 380 788 260 Get in touch Science within easy reach! Receive our general letter or our financial news! Explore Oncodesign's vitality Legal notice Personal data policy